Nexrutine® Improves Quality of Life
November 8, 2004
Nexrutine® Improves Quality of Life
IRVINE, Calif.Researchconducted on the natural antiinflammatory and painkilling effects of NextPharmaceuticals (www.nextpharmaceuticals.com) Nexrutine® product foundpositive results for quality of life issues.
The double blind, placebo-controlled trial, conducted by MiamiResearch Associates under the direction of Diane Krieger, M.D., found Nexrutinesignificantly improved quality of life issues. Post-treatment scores on theSF-36v2 Quality of Life instrument were improved significantly from thepre-treatment scores in the Nexrutine group for role physical, vitality, mentalhealth and mental component summary.
Nexrutine has an excellent safety profile, said BobGarrison, pharmacist and chief executive officer of Next Pharmaceuticals, notonly from the long-term use of the plant material used to make this proprietaryingredient, but from extensive academic research on the active compounds and ourown toxicology and human studies. Nexrutine is a patent-pending extract fromthe bark of the Phellodendron amurense tree.
You May Also Like